Withings Opens BodyScan 2 Insider Program for 500 EU Testers

The health device manufacturer Withings has opened applications for a 500-person test program centered on its upcoming BodyScan 2 smart scale. The BodyScan 2 Insider Program targets users in the European Union who will receive final production hardware before the wider market release. This is not a prototype trial—the company says participants will get production-ready units with firmware updates planned throughout the testing period.

According to reporting from Notebookcheck, the program requires applicants to complete a form and then engage in 30-minute feedback calls and surveys. Those who finish over 80% of the program requirements unlock a €70 gift card plus a one-year Withings+ subscription valued at €100. The messaging indicates the global launch is just weeks away, though no exact date has been confirmed.

Independent coverage from Gadgets & Wearables corroborates the timeline and scope. The program runs through June 2026, with firmware updates scheduled to unlock features and refine performance during that window. Selected users can purchase the BodyScan 2 weeks ahead of the global release. The company notes the US market will follow Europe soon, though no specific timeline exists for that expansion.

The BodyScan 2 itself was unveiled at CES 2026 as Withings' next flagship health scale. It monitors over 60 biomarkers through a 90-second scan. Features include hypertension notifications, cardiovascular analysis, and glycemic impact measurements. Data transfers wirelessly to the brand's app, where users receive actionable insights. The device positions itself as a home health station rather than a simple weight tracker.

Standing on the scale for 90 seconds while it measures cardiovascular metrics is a different experience than traditional smart scales. Users need to remain still while the device runs its scan, which is longer than the typical 10-15 second weight measurement. The app then processes this data into trend reports and health trajectories. Whether that extra time and complexity translates to better health outcomes remains to be seen (though the marketing certainly hopes so).

Early users may shape the final experience before the wider rollout. The Insider Program helps Withings verify how reliably the scans work in real homes, how clearly the app explains results, and whether the firmware behaves properly in daily use. More metrics only help if users understand what changed and what it means over time. The software layer needs to be as clear as the hardware pitch.

The 500-person limit keeps the rollout controlled. Withings gets real feedback from engaged users while buyers get the device before everyone else. It is a practical middle step before the global launch. The product is expected to cost $599.95/£449.95/€499.95, positioning it as a premium health device rather than a mass-market scale.

Whether users actually want this much health tracking from a bathroom scale is the real question. The direction is clear: Withings is pushing BodyScan 2 as a more complete home health device. But the market will decide if people pay nearly €500 for a scale that does more than weigh them.

Artūras Malašauskas is an AI Systems Integrator with 20+ years of production-grade web engineering experience. He has designed, shipped, and scaled enterprise Python/PHP systems for logistics, SaaS, and public-sector clients. For the past year, he has focused exclusively on AI integrations: deploying open-source LLMs, building generative media pipelines (image, audio, video), and engineering multi-agent workflows for real production environments. His standard: reproducibility, security, cost-efficient inference—no vaporware. He documents and evaluates emerging AI tooling, separating verified capabilities from marketing noise. Technical editor at: muza-ai.eu, ai-verslas.lt, ai-naujinos.lt Connect on LinkedIn